Repaglinide

Overview

Repaglinide is oral hypoglycemic agent. The onset of action is rapid but the duration of action is short. Repaglinide is used in the treatment of non-insulin dependent diabetes. It may also reduce the long term cardiovascular, cerebrovascular and renal effects of diabetes.

Categories

• 18 Hormones and other endocrine drugs and contraceptives
  • 18.7 Antidiabetics
  • 18.7.2 Oral hypoglycemics

Page headings

Primary Characterstics

Indications

Pharmacokinetics

Contraindications

Drug Interactions

Side Effects

Dosage

's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
0.5 to 2 mg	1.2 (1.25)	8 hourly	PO	Maximum dose: 4 mg.
Paedriatic Dosage (20kg)
				Not recommended in this age group
Neonatal Dosage (3kg)
				Not recommended in this age group

High Risk Groups

Warning / Precautions

Storage Conditions

Interference in Pathology

Brands / Trade Names of

Manufacturers of Repaglinide in Pakistan

Back to top